Empresa Innovus Pharmaceuticals Inc Other OTC
Acciones
US45778V1061
Farmacéuticos
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01/06/18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Mostafa Abuzeid
PRN | Corporate Officer/Principal | - | - |
Hans Christinger
PRN | Corporate Officer/Principal | - | - |
Gilbert Jaoudé
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 3 204 401 | 2 483 540 ( 77,50 %) | 0 | 77,50 % |
Información de la empresa
Innovus Pharmaceuticals, Inc.
373 Inverness Parkway Suite 206
80112, Englewood
+858-964-5123
http://www.innovuspharma.comVaria. 1 de ene. | Capi. | |
---|---|---|
+25,83 % | 661 mil M | |
+27,00 % | 566 mil M | |
-6,76 % | 352 mil M | |
+20,34 % | 332 mil M | |
+3,00 % | 283 mil M | |
+13,09 % | 231 mil M | |
+5,46 % | 200 mil M | |
-9,61 % | 195 mil M | |
-6,26 % | 145 mil M |